Clinical Trials Sponsored by Amerifit Brands Inc

Total 486 results

Duramed Research

Completed

A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

Bone Mineral Density

United States
Duramed Research

Completed

A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea

Amenorrhea

United States
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

Hematological Malignancies

United States, Canada
Duramed Research

Completed

Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement

Infertility

United States
ChemGenex Pharmaceuticals

Completed

Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors

Hematologic Tumors

United States
Duramed Research

Completed

A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.

Contraception

United States
Duramed Research

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

Infertility

United States
Gemin X

Withdrawn

Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas

Solid Tumors and Lymphomas
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

Canada, United States
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia

Myelofibrosis

United States, Canada
Duramed Research

Completed

A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes

Hot Flashes

United States
Teva Branded Pharmaceutical Products R&D, Inc.
FHI 360

Completed

Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Pregnancy | Contraception

United States
Merckle GmbH

Completed

PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants

Pharmacokinetics | Pharmacodynamics

United Kingdom
Rafa Laboratories
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Cancer

Israel
Duramed Research

Completed

A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches

Migraine

United States
Duramed Research

Completed

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

Dysmenorrhea

United States
Duramed Research

Completed

A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients

Prostate Cancer

United States, Canada
Gemin X

Terminated

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Metastatic Melanoma

United States
Duramed Research

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

Overactive Bladder

United States, Canada
CureTech Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection

Chronic Hepatitis C

Israel
Gemin X

Completed

A Phase I/II Study of GX15-070MS in Untreated CLL

Chronic Lymphocytic Leukemia

United States, Canada
Duramed Research

Completed

A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens

Healthy

United States
Duramed Research

Completed

Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain

Endometriosis

United States
Duramed Research

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy

Menopause

United States
Duramed Research

Completed

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Breakthrough Bleeding

United States
Duramed Research

Completed

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Nocturnal Vasomotor Symptoms

United States
Duramed Research

Completed

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

Urinary Incontinence

United States, Canada
The University of Texas Medical Branch, Galveston
Dairy Management Inc.

Recruiting

Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation (GRIPS)

Aging

United States
Teva Pharmaceuticals USA
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

United States, Bulgaria, Czechia, Georgia, Germany, Hungary, Poland, Russian Federation, Slovakia, Ukraine
University of Pennsylvania
Teva Branded Pharmaceutical Products R&D, Inc.

Active, not recruiting

An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia (AUDYT)

Dystonia, Primary

United States
Teva Pharma GmbH

Completed

A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Pregnancy Rate | Oocytes

Germany
Burke Rehabilitation Hospital
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke

Stroke | Hemiparesis | Cerebrovascular Accident

United States
Achieve Life Sciences
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

Cardiac Conduction and Repolarization

United States
University of Florida
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay

Asthma

United States
Hadassah Medical Organization
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures

Tibial Fracture

Israel
Child Trends
Power to Decide; Healthy Teen Network; MyHealthEd, Inc

Recruiting

Evaluation of the SafeSpace App Intervention (SafeSpace)

Health Behavior | Sexually Transmitted Infections | Health Care Utilization | Unprotected Sex

United States
University of Michigan
Teva Branded Pharmaceutical Products R&D, Inc.

Active, not recruiting

Teva Asthma Predictive Analytics Study

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Cephalon; ChemGenex Pharmaceuticals

Completed

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Chronic Myeloid Leukemia

United States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
Teva Pharma GmbH

Completed

Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Patient Satisfaction

Germany
Brenda Gallie
Phoenix Clinical Inc.

Terminated

PCI Imaging System in Pediatric Ophthalmology

Retinoblastoma

Canada
Teva Pharmaceuticals Europe

Completed

Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease (SPRINT)

Chronic Obstructive Pulmonary Disease | Asthma

Croatia, Denmark, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom
Achieve Life Sciences
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen

Cancer

United States
Teva Women's Health

Completed

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Oral Contraceptive | Hemostasis

United States, Italy
Teva Branded Pharmaceutical Products R&D, Inc.
H. Lundbeck A/S; Teva Neuroscience, Inc.

Completed

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Parkinson's Disease

United States, Argentina, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Romania, Spain, United Kingdom
Cedars-Sinai Medical Center
Band Connect, Inc

Recruiting

Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study (VirtuaCare)

Shoulder Injuries | Shoulder Disease

United States
RAND
Columbia University; Bienestar Human Services, Inc.

Completed

Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention (MOTIVES)

HIV Infections | HIV

United States
Cardio Ring Technologies, Inc. Taiwan Branch
Taipei Medical University Hospital

Recruiting

ArteVu Blood Pressure Accuracy Study (ARTEVU)

Blood Pressure

Taiwan
University of Nebraska
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections

Multiple Sclerosis

United States
Biomind Labs Inc.
Universidade Federal do Rio Grande do Norte

Completed

Clinical Study of DMT in Healthy Adults

Healthy Volunteers

Brazil
Teva Branded Pharmaceutical Products R&D, Inc.
Cephalon; ChemGenex Pharmaceuticals

Completed

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Chronic Myeloid Leukemia

United States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom

3

Subscribe